ICU Medical (NASDAQ:ICUI) Stock Price Down 6% After Insider Selling

ICU Medical, Inc. (NASDAQ:ICUI) traded down 6% during mid-day trading on Tuesday after an insider sold shares in the company. The stock traded as low as $156.95 and last traded at $157.78. 155,950 shares changed hands during mid-day trading, a decline of 43% from the average session volume of 273,648 shares. The stock had previously closed at $167.81.

Specifically, COO Christian B. Voigtlander sold 1,962 shares of the company’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $169.08, for a total transaction of $331,734.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on ICUI shares. StockNews.com upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday, November 20th. KeyCorp boosted their price objective on shares of ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research note on Wednesday, November 13th. Jefferies Financial Group assumed coverage on ICU Medical in a report on Monday, October 14th. They set a “hold” rating and a $183.00 price objective for the company. Raymond James lifted their target price on ICU Medical from $158.00 to $190.00 and gave the company an “outperform” rating in a report on Thursday, September 12th. Finally, Needham & Company LLC restated a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, ICU Medical presently has an average rating of “Moderate Buy” and a consensus price target of $173.00.

ICU Medical Stock Up 1.3 %

The firm’s 50-day moving average price is $175.61 and its 200-day moving average price is $146.51. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The company has a market cap of $3.91 billion, a price-to-earnings ratio of -34.96 and a beta of 0.66.

Institutional Trading of ICU Medical

Several large investors have recently added to or reduced their stakes in ICUI. Vanguard Group Inc. boosted its position in shares of ICU Medical by 0.5% in the first quarter. Vanguard Group Inc. now owns 2,452,720 shares of the medical instruments supplier’s stock worth $263,226,000 after buying an additional 11,991 shares during the period. State Street Corp boosted its holdings in ICU Medical by 9.3% in the 3rd quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier’s stock worth $165,384,000 after acquiring an additional 77,506 shares during the period. Geode Capital Management LLC boosted its holdings in ICU Medical by 9.6% in the 3rd quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier’s stock worth $99,687,000 after acquiring an additional 48,106 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of ICU Medical by 21.7% during the second quarter. Dimensional Fund Advisors LP now owns 311,542 shares of the medical instruments supplier’s stock valued at $36,996,000 after purchasing an additional 55,588 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of ICU Medical by 10.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 301,107 shares of the medical instruments supplier’s stock valued at $54,868,000 after purchasing an additional 27,927 shares during the period. 96.10% of the stock is currently owned by institutional investors and hedge funds.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.